Gelclair oral gel.
Buchsel
Patricia C
PC
School of Nursing, University of Washington, Seattle, USA. pbuchsel@nwlink.com
D000287:Administration, Topical; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004338:Drug Combinations; D005782:Gels; D006801:Humans; D006820:Hyaluronic Acid / Q000627:therapeutic use*; D009059:Mouth Diseases / Q000188:drug therapy* / Q000451:nursing; D009061:Mouth Mucosa / Q000187:drug effects; D010353:Patient Education as Topic; D011205:Povidone / Q000627:therapeutic use*; D012307:Risk Factors; D012680:Sensitivity and Specificity; D016896:Treatment Outcome
D004338:Drug Combinations; C439265:Gelclair; D005782:Gels; D006820:Hyaluronic Acid; D011205:Povidone